Combination atezolizumab, bevacizumab, pemetrexed and carboplatin for metastatic EGFR mutated NSCLC after TKI failure by Lam, T.C., Tsang, K.C., Choi, H.C., Lee, V.H., Lam, K.O., Chiang, C.L., So, T.H., Chan, W.W., Nyaw, S.F., Lim, F., Lau, J.O., Chik, J., Kong, F.M., Lee, A.W.

Get full text

MA16.02 T790M Allelic Fraction Level Did Not Correlate Survival in T790M Positive NSCLC – Observations from an Early Access Program by Chan, O.S.H., Lam, K.C., Lee, V., Nyaw, S.F., Yeung, M.W.R.

Get full text

EP-1391: EGFR/ALK Mutations in Stage III Non-small Cell Lung Cancer Patients Received Chemoradiotherapy by Nyaw, S.F., Tin, W.Y., Lo, S.H., Tung, Y.

Get full text

EP-1653: Prognostic factors in stereotactic body radiotherapy to bony oligometastatses from solid tumors by Mui, W.H., Nyaw, S.F., Wong, M.Y.P., Leung, R.W.K., Wong, F.C.S.

Get full text

P37.15 Prevalence of Targetable Mutations using a RT-qPCR Multiplex Assay in Asian NSCLC Patients: A Single Laboratory Experience by Nyaw, S.F., Lee, K., Lai, T.W., Lo, P.Y., Choy, C.T., Kwong, T.C., Lau, Y.T.N., Lin, L., Lau, S.W.

Get full text

Can Quantitative Measures of T790M Allelic Fraction Predict Survival Outcomes in Patients Receiving Osimertinib? Observations From an Early Access Programme by Chan, O.S.H., Lee, V.H.F., Nyaw, S.F., Kam, M.T.Y., Lee, K.W.C., Lam, K.C.

Get full text

169P Genomic landscape of NSCLC brain metastases and its potential association with TP53 and tumor mutation burden: A territory-wide program in Hong Kong by Kam, T.Y., Wong, C.H.L., Fong, J.K.S., Lee, V.H.F., Chiu, M.K.L., Cheung, K.M., Nyaw, S.F., Lim, M.Y., Kwan, C.K., Mok, S.T.F., Lee, A.W.M.

Get full text

51P Exploring the prognostic value of TP53 mutation in NSCLC in the era of precision oncology: A prospective real-world study by Chiu, M.K.L., Wong, C.H.L., Fong, J.K.S., Ko, E.Y-L., Lee, V.H.F., Kam, T.Y., Cheung, K.M., Nyaw, S.F., Kwan, C.K., Mok, S.T.F., Lee, A.W.M., Lim, M.Y.

Get full text

175P Quality of life in patients with NSCLC brain metastases undergoing different local therapies in the era of precision oncology: A territory-wide study by Wong, C.H.L., Kam, T.Y., Fong, J.K.S., Lee, V.H.F., Chiu, M.K.L., Cheung, K.M., Nyaw, S.F., Lim, M.Y., Kwan, C.K., Mok, S.T.F., Lee, A.W.M.

Get full text

Best practices in epidermal growth factor receptor T790M testing for advanced non-small-cell lung cancer in Hong Kong by Nyaw, J S F, Cheung, K M, Hioe, F, Kam, M T Y, Lau, J K S, Lau, Y M, Leung, D K C, Lim, F M Y

Get full text

Risk of Radiation Pneumonitis after Post-lobectomy Thoracic Radiotherapy for Non-small-cell Lung Cancer by Chan, W, Nyaw, JSF, Tin, WWY, Lee, EKC, Lo, SH, Liu, ACH, Wong, FCS

Get full text